Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia

被引:13
|
作者
Maugeais, C
Ouguerram, K
Frénais, R
Maugère, P
Charbonnel, B
Magot, T
Krempf, M [1 ]
机构
[1] Hotel Dieu, Clin Endocrinol, F-44093 Nantes 01, France
[2] Hotel Dieu, Ctr Rech Nute Humaine, F-44093 Nantes 01, France
来源
关键词
D O I
10.1210/jc.86.4.1679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The acute reduction of low-density lipoprotein (LDL) cholesterol obtained by LDL-apheresis allows the role of the high level of circulating LDL on lipoprotein metabolism in heterozygous familial hypercholesterolemia (heterozygous FH) to he addressed. We studied apolipoprotein B (apoB) kinetics in five heterozygous FH patients before and the day after an apheresis treatment using endogenous labeling with [(2)H(3)]leucine. Compared with younger control subjects, heterozygous FH patients before apheresis showed a significant decrease in the fractional catabolic rate of LDL (0.24 +/- 0.08 vs. 0.65 +/- 0.22 day(-1); P < 0.01), and LDL production was increased in heterozygous FH patients (18.9 +/- 7.0 vs. 9.9 +/- 4.2 mg/kg.day; P < 0.05). The modeling of postapheresis apoB kinetics was performed using a nonsteady state condition, taking into account the changing pool size of very low density lipoprotein (VLDL), intermediate density lipoprotein, and LDL apoB. The postapheresis kinetic parameters did not show statistical differences compared with preapheresis parameters in heterozygous FH patients; however, a trend for increases in fractional catabolic rate of LDL (0.24 +/- 0.08 vs. 0.35 +/- 0.09 day(-1); P = 0.067) and the production of VLDL (13.7 +/- 8.3 vs. 21.9 +/- 1.6 mg/ kg day; P = 0.076) was observed. These results suggested that the marked decrease in plasma LDL obtained a short time after LDL-apheresis is able to stimulate LDL receptor activity and VLDL production in heterozygous FH.
引用
收藏
页码:1679 / 1686
页数:8
相关论文
共 50 条
  • [41] Low-density lipoprotein apheresis with different intervals in patients with homozygous familial hypercholesterolemia: does time matter?
    Temizhan, A.
    Cetin, E. H. Ozcan
    Cetin, M. S.
    Tak, B. Tekin
    EUROPEAN HEART JOURNAL, 2018, 39 : 1109 - 1109
  • [42] COMPARED TOTAL PLASMA-EXCHANGE AND LOW-DENSITY LIPOPROTEIN APHERESIS IN SEVERE FORMS OF FAMILIAL HYPERCHOLESTEROLEMIA
    DAIROU, F
    ROTTEMBOURG, J
    DEGENNES, JL
    ASSOGBA, U
    BRUCKERT, E
    JACOBS, C
    TRUFFERT, J
    PRESSE MEDICALE, 1988, 17 (33): : 1679 - 1682
  • [43] Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial Hypercholesterolemia
    Hudgins, Lisa C.
    Kleinman, Bryan
    Scheuer, Abby
    White, Sharon
    Gordon, Bruce R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (09): : 1199 - 1204
  • [44] Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its atherosclerotic vascular complications: Dextran sulfate cellulose low-density lipoprotein apheresis
    Keller, C
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (03) : 345 - 349
  • [45] EFFECTS OF COLESTIPOL ON LOW-DENSITY-LIPOPROTEIN IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    SUNDBERG, EE
    ILLINGWORTH, DR
    ARTERIOSCLEROSIS, 1987, 7 (05): : A513 - A513
  • [46] Low-density lipoprotein-apolipoprotein B metabolism following apheresis: Simulation studies of mass changes and tracer kinetics
    Barrett, PHR
    Parhofer, KG
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (04): : 478 - 483
  • [47] Effect of Low-Density Lipoprotein Apheresis on Plasma Levels of Apolipoprotein E4
    Moriarty, Patrick M.
    Luyendyk, James P.
    Gibson, Cheryl A.
    Backes, James M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (11): : 1585 - 1587
  • [48] TREATMENT OF HOMOZYGOTIC FAMILIAL HYPERCHOLESTEROLEMIA WITH CONTINUOUS APHERESIS OF LOW-DENSITY LIPOPROTEINS
    TERUEL, JL
    LASUNCION, MA
    CASTANON, MA
    GALLEGO, N
    HERRERA, E
    ORTUNO, J
    MEDICINA CLINICA, 1991, 97 (19): : 738 - 740
  • [49] A novel deletion/inversion mutation in the low-density lipoprotein receptor gene as a cause of heterozygous familial hypercholesterolemia
    Koivisto, UM
    Kontula, K
    HUMAN MUTATION, 1996, 8 (04) : 326 - 332
  • [50] NORMALIZATION OF LOW-DENSITY LIPOPROTEIN LEVELS AND DISAPPEARANCE OF XANTHOMAS DURING PREGNANCY IN A WOMAN WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MABUCHI, H
    SAKAI, Y
    WATANABE, A
    HABA, T
    KOIZUMI, J
    TAKEDA, R
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (04): : 309 - 315